Tuesday, September 30, 2014

MIT Holding, Inc. (MITD) Partnership Commences Treatment of Patients in Phase 3 FDA Clinical Trial With SERRG | Publicwire


MIT Holding, Inc. (OTCQB: MITD) announces the intake of patients for a FDA clinical trial.
http://bit.ly/1vtynzq
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)